Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ABVX stock hub

ABIVAX Société Anonyme has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ABVXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

9.8B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ABVX

In the news

Latest news · ABVX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-135.6

P25 -106.6P50 -46.9P75 -3.1

ROIC-48.3

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ABVX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

200

Groups with data

Currency

EUR

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001956827
Company name	ABIVAX Société Anonyme
Country	France
Country code	US
Cusip	00370M103
Employees	69
Employees Change	0%
Employees Change Percent	0
Enterprise value	$9.2B
Exchange	NASDAQ
Financial currency	EUR
First seen	2026-05-09
Industry	Biotechnology
Isin	US00370M1036
Last refreshed	2026-05-10
Market cap	$9.8B
Market cap category	Mid-Cap
Price	$123
Price currency	USD
Rev Per Employee	77,764.33x
Sector	Healthcare
Sic	2834
Symbol	ABVX
Website	https://www.abivax.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.01%
EV Sales Forward	1,813.02x
EV/Sales	1,723.23x
FCF yield	-1.93%
P/B ratio	18.4x
P/S ratio	1,832.53x
PS Forward	1,928.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$5.4M
Gross Profit Growth	-63.22%
Gross Profit Growth Q	-55.37%
Gross Profit Growth3 Y	0.48%
Net Income	$-394.6M
Net Income Growth Years	0%
Pretax Margin	-7,226.56%
Profit Per Employee	$-5.7M
ROA	-38.95
Roa5y	-37.56
ROCE	-47.2
ROE	-135.6
Roe5y	-198.1
ROIC	-48.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	1,756.39%
EPS Growth Years	0
Revenue Growth	-63.22x
Revenue Growth Q	-55.37x
Revenue Growth Years	0x
Revenue Growth3 Y	0.48x
Revenue Growth5 Y	218.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$686.1M
Cash	$622.7M
Current Assets	$650.1M
Current Liabilities	$74.3M
Debt	$37.7M
Debt Equity	$0.07
Equity	$534.5M
Interest Coverage	-8.64
Liabilities	$151.6M
Long Term Assets	$36M
Long Term Liabilities	$77.3M
Net Cash	$585.1M
Net Cash By Market Cap	$5.95
Net Cash Growth	1,318.05%
Net Debt Equity	$-1.09
Tangible Book Value	$505.1M
Tangible Book Value Per Share	$6.43
WACC	3.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.75
Net Working Capital	$-48M
Quick ratio	8.58
Working Capital	$573.2M
Working Capital Turnover	$0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.28%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	1,752.68%
200-day SMA	105.6
50-day SMA	116.6
50-day SMA vs 200-day SMA	50over200
All Time High	148.8
All Time High Change	-17.53%
All Time High Date	2025-12-24
All Time Low	4.77
All Time Low Change	2,473.17%
All Time Low Date	2025-04-09
ATR	5.65
Beta	-0.1
Ch YTD	-8.98
High	126.7
High52	148.8
High52 Date	2025-12-24
High52ch	-17.53%
Low	121.2
Low52	5.59
Low52 Date	2025-05-23
Low52ch	2,095.71%
Ma50ch	5.25%
Premarket Change Percent	0.11
Premarket Price	$125
Premarket Volume	14,649
Price vs 200-day SMA	16.21%
RSI	55.34
RSI Monthly	75.23
RSI Weekly	55.73
Sharpe ratio	1.19x
Sortino ratio	20.46
Total Return	-10.28%
Tr YTD	-8.98
Tr1m	5.37%
Tr1w	4.36%
Tr3m	4.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	13
Analyst Count Top	8
Analyst Price Target Top	$142
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-4.91
Earnings Revenue Estimate	5,510,000x
Earnings Revenue Estimate Growth	-58.53x
Operating Income	$-288.9M
Operating margin	-5,384.1
Price target	$131
Price Target Change	$6.98
Price Target Change Top	$15.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	64,135,279%
Float Percent	80.99%
Net Borrowing	-70,207,155.5
Shares Insiders	0.63%
Shares Institutions	98.84%
Shares Out	79,185,160
Shares Qo Q	7.21%
Shares Yo Y	10.28%
Short Float	3.99%
Short Ratio	2.38
Short Shares	3.23

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-231.7M
Average Volume	904,646.5x
Bv Per Share	6.81
CAPEX	$-166,725
Ch1m	5.37
Ch1w	4.36
Ch1y	1,752.7
Ch3m	4.31
Ch6m	16.6
Change	-1.53%
Change From Open	-1.68
Close	124.7
Days Gap	0.15
Depreciation Amortization	1,264,207.6
Dollar Volume	112,625,978.5
Earnings Date	2026-03-23
Earnings Time	amc
EBIT	$-288.9M
EBITDA	$-287.6M
EPS	$-5.68
F Score	3
FCF	$-190.2M
FCF EV Yield	-2.06x
FCF Per Share	$-2.4
Financing CF	642,605,378
Fiscal Year End	December
Founded	2,013
Goodwill	21,721,492.2
Income Tax	$6.9M
Investing CF	-9,619,584
Ipr	958.1
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-03-23
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-23
Ma150	114.9
Ma150ch	6.82%
Ma20	118
Ma20ch	4.06%
Net CF	437,318,305
Next Earnings Date	2026-08-10
Open	124.8
Optionable	Yes
Position In Range	27.67
Post Close	122.7
Postmarket Change Percent	-0.02
Postmarket Price	$123
Ppne	2,464,733.1
Pre Close	124.7
Price Date	2026-05-08
Ptbv Ratio	19.47
Relative Volume	1.01x
Revenue	5,365,739x
SBC By Revenue	774.55x
Share Based Comp	41,560,409
Tax By Revenue	127.96x
Tr6m	16.6%
Volume	917,598
Z Score	11.71

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ABVX pay a dividend?

Capital-return profile for this ticker.

Performance

ABVX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ABVX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+98.8%

Float: +81.0% of shares outstanding

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ABVX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.3

Neutral momentum band

Price vs 200-day MA

+16.2%

50/200-day relationship not available

Beta (5Y)

-0.10

Less volatile than the market

Sharpe ratio

1.19

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ABVX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ABVX stock rating?

ABIVAX Société Anonyme is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ABVX analysis?

The full report lives at /stocks/ABVX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ABVX?

The latest report frames ABVX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ABVX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.